Michael Loffredo, MD
Plastic Surgery · Hyannis, MANPI 1679653430
Payments from drug & device makers
What this record shows
The money is spread across several categories — gifts (49.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. AbbVie accounts for 76.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $5,920 and has fallen 90.1% since, to $587 in 2025.
Across 157 payments — averaging $69.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$8K
- Heron Therapeutics, Inc.$2K
- Sientra, Inc.$337
- Merz North America, Inc.$285
- Revance Therapeutics, Inc.$200
- Mentor Worldwide LLC$89
- plus $149 from 5 others
What the payments were for
- Consulting fees$1,50014%
- Food & beverage$4,07137%
- Gifts$5,40049%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 119 | $8,411 |
| Heron Therapeutics, Inc. | 1 | $1,500 |
| Sientra, Inc. | 11 | $337 |
| Merz North America, Inc. | 10 | $285 |
| Revance Therapeutics, Inc. | 6 | $200 |
| Mentor Worldwide LLC | 4 | $89 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $69 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Johnson & Johnson | 1 | $23 |
| Baudax Bio Inc. | 1 | $16 |
| TELA Bio, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE$5,400
- HTX-011$1,500
- NATRELLE SALINE-FILLED BREAST IMPLANTS$249
- BOTOX COSMETIC$103
How this compares
$10,971 in reported general payments places this provider in the 85th percentile of 113 plastic surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 63 | $198 |
| Cephalexin | 36 | $164 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $101 |
| Oxycodone Hcl | 12 | $49 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Hyannis
- Seth JonesHyannis$7K
- Marc FaterHyannis$1K
- William AustenBoston$150K
- Daniel DelvecchioBoston$141K
- Edward KobraeiBoston$78K
- Samuel LinBoston$72K
- Michael TantilloChestnut Hill$71K
- Katherine CarruthersBoston$55K
- Vickram TandonJamaica Plain$51K
- Sean DohertyBrookline$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.